Federal Court of Appeal finds Minister of Health’s refusal to grant a CSP for SHINGRIX is reasonable
By EsqSocial Corporation 29/04/21
In the first appellate decision relating to Certificates of Supplementary Protection (CSPs), the Federal Court of Appeal has allowed the appeal of the Minister of Health (the Minister), setting aside the lower court judgment. In a unanimous decision released on April 14, 2021, the Federal Court of Appeal in Canada (Health) v Glaxosmithkline Biologicals S.A., 2021 FCA 71 found that the Federal Court... did not correctly apply the applicable standard of review....
By: Smart & Biggar